Outcome of Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia After Blinatumomab Failure: No Change in the Level of CD19 Expression

American Journal of Hematology - United States
doi 10.1002/ajh.24987
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Potent Anti-Leukemia Activities of Humanized CD19-targeted CAR-T Cells in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

American Journal of Hematology
Hematology
2018English

Correlates of Resistance and Relapse During Blinatumomab Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia

American Journal of Hematology
Hematology
2017English

Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia

Advances in Therapy
MedicinePharmacology
2019English

Blinatumomab in Acute Lymphoblastic Leukemia

Expert Review of Anticancer Therapy
OncologyPharmacology
2016English

Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2019English

Pcn77 - Budget Impact Analysis of Blinatumomab for the Treatment of Pediatric Patients With Philadelphia Negative Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in Mexico

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) Among Adults With Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) Achieving Remission With Blinatumomab

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

In Vitro Cellular Drug Resistance in Children With Relapsed/Refractory Acute Lymphoblastic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
1995English

Phase I and Extension Study of Clofarabine Plus Cyclophosphamide in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy